BMY vs EIX · P/E 17, rev $48.19B vs P/E 7.3, rev $17.60B
Bristol-Myers Squibb Company (BMY) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the BMY and EIX stock pages for the full models.
Not investment advice.